发明授权
US09150513B2 Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
有权
4-叔丁基-N- [4-氯-2-(1-氧 - 吡啶-4-羰基) - 苯基] - 苯磺酰胺的钠盐的多晶型形式
- 专利标题: Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
- 专利标题(中): 4-叔丁基-N- [4-氯-2-(1-氧 - 吡啶-4-羰基) - 苯基] - 苯磺酰胺的钠盐的多晶型形式
-
申请号: US14234279申请日: 2012-07-20
-
公开(公告)号: US09150513B2公开(公告)日: 2015-10-06
- 发明人: Joanna Bis , David H. Igo
- 申请人: Joanna Bis , David H. Igo
- 申请人地址: US CA Mountain View
- 专利权人: ChemoCentryx, Inc.
- 当前专利权人: ChemoCentryx, Inc.
- 当前专利权人地址: US CA Mountain View
- 代理机构: Brinks Gilson & Lione
- 代理商 Ryan L. Marshall
- 国际申请: PCT/US2012/047513 WO 20120720
- 国际公布: WO2013/016156 WO 20130131
- 主分类号: C07D211/70
- IPC分类号: C07D211/70 ; C07D213/89 ; A61K31/44
摘要:
Disclosed are novel polymorphic solvated and desolvated forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)phenyl]-benzenesulfonamide. One embodiment of the present invention is directed to a crystalline sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]benzenesulfonamide (hereinafter “Compound A-1,4-dioxane/water solvate”), wherein the crystalline form is characterized by an X-ray powder diffraction pattern comprising diffraction angles (° 28), when measured using Cu Ku radiation, at about 4.0, 8.1, 10.1, 14.2, 16.2, 18.6, 20.3, 24.7, 25.0, and 26.5.
公开/授权文献
信息查询